Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34876409

Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Discov
Publication date
2022 Mar 1
First author
Friedman CF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2022 Mar 1;12(3):602-603. doi: 10.1158/2159-8290.CD-21-1642.
    note
    Source null
    related pmid
    35257152
    relationship
    Comment in

Authors and identifiers

  1. name
    Friedman CF
    type
    Author
  2. name
    Hainsworth JD
    type
    Author
  3. name
    Kurzrock R
    type
    Author
  4. name
    Spigel DR
    type
    Author
  5. name
    Burris HA
    type
    Author
  6. name
    Sweeney CJ
    type
    Author
  7. name
    Meric-Bernstam F
    type
    Author
  8. name
    Wang Y
    type
    Author
  9. name
    Levy J
    type
    Author
  10. name
    Grindheim J
    type
    Author
  11. name
    Shames DS
    type
    Author
  12. name
    Schulze K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Friedman CF
    type
    Author
  2. name
    Hainsworth JD
    type
    Author
  3. name
    Kurzrock R
    type
    Author
  4. name
    Spigel DR
    type
    Author
  5. name
    Burris HA
    type
    Author
  6. name
    Sweeney CJ
    type
    Author
  7. name
    Meric-Bernstam F
    type
    Author
  8. name
    Wang Y
    type
    Author
  9. name
    Levy J
    type
    Author
  10. name
    Grindheim J
    type
    Author
  11. name
    Shames DS
    type
    Author
  12. name
    Schulze K
    type
    Author
bibliography ids
  1. nci-bib-01461b5904d3b6e568d1bf89
book metadata
content sha256
f1e1aa18fdfac6605bb18d388f154d7dbf653deb5b94205b7a56e37b45ed53ed
document type
citation
dois
  1. 10.1158/2159-8290.CD-21-0450
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34876409
immutable id
pubmed:34876409@f1e1aa18fdfac6605bb18d388f154d7dbf653deb5b94205b7a56e37b45ed53ed
journal
abbreviation
Cancer Discov
issn electronic
2159-8290
issn print
2159-8274
issue
3
name
Cancer discovery
nlm unique id
101561693
pages
654-669
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2022 Mar 1;12(3):602-603. doi: 10.1158/2159-8290.CD-21-1642.
    note
    Source null
    related pmid
    35257152
    relationship
    Comment in
outcomes validated
false
pmid
34876409
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
158cf95580f6f681f1700490c6bfdebbc2ed3843970585b6de175367412d13f3
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Mar 1
precision
day
year
2022
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34876409/
title
Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study.

Preserved source evidence · Independent clinical review pending · Not medical advice